Extranodal NK_T expression list

Flow
Tutorial

Myeloproliferative neoplasms	Neoplasms with eosinophilia (PDGRA/PDGFRB/FGFR1)	MDS/MPN	MDS	AML	Acute leukemia ambiguous lineage
Precursor lymphoid neoplasms	Mature B cell neoplasms	Mature T and NK neoplasms	Hodgkin lymphoma	Immunodeficiency associated lymphoproliferative disorders	Histiocytic and dendritic cell neoplasms

Extranodal NK/T Cell Lymphoma, Nasal Type
	Unusual antigen expression abstracts	Prognostic abstracts	Cytogenetic abstracts	Antigen chart

T cell large granular lymphocytic leukemia

Chronic lymphopoliferative disorder of NK cells

Aggressive NK cell leukemia

Epstein-Barr virus (EBV) positive T cell lymphoproliferative diseases of childhood

Adult T cell leukemia/lymphoma

Enteropathy-associated T cell lymphoma

Subcutaneous panniculitis-like T cell lymphoma

Mycosis fungoides

Sezary syndrome

Primary cutaneous CD30 positive T cell lymphoproliferative disorders

Primary cutaneous peripheral T cell lymphomas, rare subtypes

Article	Antigens evaluated
Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.	CD8, CD56, p58.1, p58.2, p70, p140, CD94, NKG2, and leukocyte immunoglobulin-like receptor (LIR-1)
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.	CD30, Granzyme B, TIA-1, EBER